Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: detoxification

November 17, 2025 CD as API / Pharma applications

Cyclodextrins as Active Therapeutic Agents: Beyond Their Role as Excipients

Cyclodextrins (CDs) have traditionally been recognized as excipients that enhance solubility and stability of drugs. However, growing evidence shows that

Continue reading

September 26, 2024 CD as API / CD derivatives / Pharma applications

The revival of cyclodextrins as active pharmaceutical ingredients 

Cyclodextrins have long been known as host molecules, a special feature that has led to their widespread use in a

Continue reading

September 22, 2022 Drug delivery / Events / Pharma applications

Inaugural Lecture of Prof. Szente at the Hungarian Academy of Sciences

Lajos Szente, Ph.D., D.Sc., one of the founders and former CEO (now Scientific Advisor) of CycloLab at the company and

Continue reading

September 18, 2022 CD as API / Pharma applications

Application of cyclodextrins for detoxification purposes and/or as antidotes: Still more questions than answers

Microencapsulation of drugs with cyclodextrins (CDs) is a commonly applied strategy to solubilize lipophilic drugs in aqueous environment and/or to

Continue reading

March 17, 2022 Environmental / Non-pharma applications

HPBCD as detoxification agent for disinfection byproducts

The health effects of disinfection byproducts (DBPs) in drinking water drew great attention recently. Herein, by using in vitro (fluorescence quenching, UV

Continue reading

Recent Posts

  • Special Issue “Cyclodextrin-Functionalized Materials for Drug Delivery, Pharmaceutical and Medical Applications”
  • Cyclodextrin-Based Oral Solution of Ursodeoxycholic Acid Using a Ready-to-Use Vehicle
  • Cyclodextrin-based electrochemical sensors for PFAS detection
  • FDA: Inclusion complex of a GRAS guest and a GRAS host is also GRAS
  • HPBCD for the treatment of irreversible white matter injury

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (72)
  • CD as API (350)
  • CD derivatives (422)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (803)
  • E-ducation (63)
  • Environmental (140)
  • Events (236)
  • Food (229)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (408)
  • Other industrial use (110)
  • Pharma applications (1,200)
  • Supramolecular systems (44)
  • Uncategorized (161)

Top Posts

  • Molecular-level enhanced clusterization-triggered emission of nonconventional luminophores in dilute aqueous solution
  • 4th International Biotechnology Congress 2020
  • Remdesivir interactions with sulfobutylether-b-cyclodextrins: A case study using selected substitution patterns
  • Methyl BCD for axon regeneration after injury - PNAS cover paper
  • The scent of Christmas tree
  • Effects of β-cyclodextrin bead polymer on the quality of wines
  • Complexation of cholesterol with β-cyclodextrin derivatives: A combined theoretical and experimental study
  • Cyclodextrin complexation of selected tyrosine kinase inhibitors
  • New book: Host-Guest Polymer Complexes
  • Treatment of Niemann-Pick Disease Type C using crosslinked 2-hydroxypropyl-β-cyclodextrin

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,475 other subscribers

Loading Comments...